Who is affected by this change?

This affects Blue Cross Blue Shield of Rhode Island Oncology, Hematology, General Surgery, Plastic Surgery, OB-GYN providers in RI on All Plans plans.

When does this change take effect?

This change is effective Apr 1, 2024.

Back to dashboard

All PlansCoverageMedium impact

New policies

Blue Cross Blue Shield of Rhode Island·RI · Oncology, Hematology, General Surgery +2 more·Physician / Facility

Effective date

Apr 1, 2024

We identified it

Jun 19, 2026

Days to comply

—

Summary

BCBS Rhode Island has created two new medical policies: Axillary Reverse Mapping for the Prevention of Breast Cancer-Related Lymphedema and Genetic Testing for Inherited Thrombophilia. These policies establish coverage criteria and billing guidelines for these specific services.

Action Required

Action needed

Immediately: Review the full text of both new policies on bcbsri.com under Medical Policy heading to understand coverage criteria, billing requirements, and documentation needs for axillary reverse mapping procedures and genetic testing for inherited thrombophilia. Update billing workflows and prior authorization processes as specified in the detailed policy text.

Related policy hubs

Blue Cross Blue Shield of Rhode Island policies RI policy changes Oncology Hematology General Surgery Plastic Surgery OB-GYN